Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the study information, blocking access to the NCT03832569 details and related content while the site chrome remains visible.SummaryDifference17%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record shows a revision update to v3.6.6. This indicates a minor maintenance/formatting update to the page rather than a change to study data, eligibility criteria, or results.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing v3.6.4. This reflects a minor internal template update with no change to study information or user-facing content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now shows a new revision tag (v3.6.4) replacing the previous v3.6.3. This indicates a minor maintenance update to the page rather than changes to the study details.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a version update to the page template. No substantive study content appears to be changed.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling an internal update to the page framework. The visible study details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.